Masimo stock surged Wednesday on its upbeat earnings and 2025 outlook, though one analyst cautioned cost reductions could ...

Masimo (NASDAQ:MASI – Get Free Report) had its price objective upped by equities researchers at Piper Sandler from $210.00 to $215.00 in a report released on Wednesday,Benzinga reports. The brokerage ...

What Happened? Shares of medical tech company Masimo (NASDAQ:MASI) jumped 11.6% in the afternoon session after the company ...

Wells Fargo raised the firm’s price target on Masimo (MASI) to $205 from $193 and keeps an Overweight rating on the shares. The firm is ...

Masimo says strategic realignment efforts near the end of last year increased the digital health pioneer's earnings power.

Masimo impressed with a robust earnings report driven by its healthcare segment, despite challenges from non-healthcare ...

BTIG analyst Marie Thibault raised the firm’s price target on Masimo (MASI) to $206 from $178 and keeps a Buy rating on the shares after its Q4 ...

Masimo Corporation’s MASI share price has surged by 12.35%, which has investors questioning if this is right time to sell.

Masimo Corp (MASI) reports robust financial performance with a 9% revenue increase, while navigating strategic realignment ...

In its fourth-quarter earnings report, the medical technology maker guided for adjusted earnings per share of $5.10 to $5.40 in 2025, ahead of the $4.69 a share analysts polled by FactSet were ...

Masimo's fourth-quarter 2024 results continue to benefit from the strength in its Healthcare and Non-healthcare businesses.

Medtech companies have their eye on the growing hospital-at-home market, which is driven largely by the rising elderly ...